微芯生物：股东博奥生物计划减持不超过约1223万股公司股份

Group 1 - The core point of the article is that Shenzhen Microchip Biotech Co., Ltd. announced a planned share reduction by its major shareholder, BGI Group, due to strategic funding needs [1] - BGI Group currently holds approximately 34.71 million shares of Microchip Biotech, representing 8.51% of the total share capital [1] - BGI Group intends to reduce its holdings by up to approximately 12.23 million shares within six months, utilizing both centralized bidding and block trading methods [1] Group 2 - The revenue composition for Microchip Biotech in 2024 is projected to be 97.96% from the pharmaceutical manufacturing industry and 2.04% from other businesses [1] - As of the announcement, Microchip Biotech has a market capitalization of 13.7 billion yuan [1]